T 0468/20 (Aptamers for use in therapy of autoimmune diseases/CHARITÉ/MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN) of 17.03.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T046820.20230317
- Date of decision
- 17 March 2023
- Case number
- T 0468/20
- Petition for review of
- -
- Application number
- 16172486.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- USE OF APTAMERS IN THERAPY AND/OR DIAGNOSIS OF AUTOIMMUNE DISEASES
- Applicant name
- Charité - Universitätsmedizin Berlin
MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN - Opponent name
- -
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 54(5)European Patent Convention Art 84Rules of procedure of the Boards of Appeal Art 11Rules of procedure of the Boards of Appeal Art 13(2)
- Keywords
- Main request and auxiliary requests 1 and 2 - lack of clarity (yes)
Auxiliary request 3 - lack of clarity (no)
Amendment after summons - exceptional circumstances (yes)
Remittal - (yes) - Catchword
- No protection according to Article 54(5) EPC for a device
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution.